Recent discussions have emerged surrounding federal health care policies, specifically related to transgender treatment for minors. Advocates from conservative watchdog groups are urging transparency about a study initiated during the Obama administration that evaluated the effects of certain hormonal therapies on young people.
Mike Howell, president of the Surveillance Project, expressed in an interview that administering puberty blockers to adolescents draws parallels to the “modern Tuskegee experiment.” He strongly believes that the National Institutes of Health (NIH) shouldn’t be allowed to keep the findings of this research under wraps.
The NIH had previously funded a grant in 2014 for Children’s Hospital, leading to studies conducted by pediatricians in Los Angeles. Now, in 2024, Rep. Lisa McClain, a Republican from Michigan, has raised questions about why Dr. Johanna Olson-Kennedy, a leading researcher, hasn’t released the results of a $9.7 million survey.
Legal challenges have arisen as groups push for the release of documents linked to the use of adolescent blockers, citing a Biden-era cover-up. McClain, in her correspondence, mentioned the NIH’s responsibility to ensure transparency and integrity in funded research.
Howell indicated that during the Trump administration, he called for the NIH to publicize these results. Interestingly, Olson-Kennedy noted that a significant number of participants reported experiencing depression.
Additionally, courts have recently upheld an Oklahoma law that prohibits gender transition treatments for those under 18. Howell highlighted a potential connection between rising incidents of violence connected to transgender ideology and an increase in mental health issues among youth.
The matter gained traction when America First Legal—a group affiliated with Stephen Miller—filed a lawsuit seeking access to FDA documentation regarding off-label usage of hormones for adolescents. Howell insisted that the public has a right to understand the implications of these substances on youth health.
In a more specific critique, HHS Secretary Robert F. Kennedy Jr. addressed concerns about adolescent blockers, which he described as a form of “castration.” He argued that minors typically lack the maturity to make such significant medical decisions.
Moreover, Neil Cornett, representing the legal case, expressed a desire to uncover internal NIH reports concerning the long-term effects of drugs like Lupron and Supprelin on young individuals. He raised alarming scenarios about potential health complications stemming from the use of these blockers.
Reflecting on historical precedents, Howell noted the troubling similarities he sees between past medical experiments, such as the Tuskegee study, and current practices involving adolescent hormonal treatments. This comparison speaks to the ethical discussions that are ongoing.
Fox News Digital reached out to Children’s Hospital in Los Angeles, which was linked to Olson-Kennedy, but contact information appears to have been disconnected. Olson-Kennedy mentioned previously that funding delays were responsible for her inability to publish data promptly.
